ETHZilla

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

ETHZilla company profile

ETHZilla is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University.

Business identity

Phone number
(650) 507-0669
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2013-01-01, Year

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$457.6M
Last funding
Post IPO Debt / $350M / 2025-09-22
Last equity funding
Post IPO Equity
Investors
15
Lead investors
1
Founders
3
Articles
169
Exited on
2020-11-09

Founders and investors

Founders

Lawrence SteinmanMarc FeldmannRaphael Mechoulam

Lead investors

Peter Thiel

Investors

Electric CapitalGSRPeter ThielPolychainRobert Leshner